Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Xeris Biopharma Holdings

Xeris Biopharma Holdings: Q1 Earnings Insights

Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Benzinga · Apr 28, 2022

Analyst Ratings For Xeris Biopharma Holdings

Xeris Biopharma Holdings (NASDAQ:XERS) has observed the following analyst ratings within the last quarter:

Benzinga · Mar 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Xeris Biopharma Holdings Q4 Earnings

Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 10, 2022

Coverage From

Benzinga

People

William Blair

56 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.